Insurance Coverage of Biosimilars: How Prior Authorization and Tier Placement Block Affordable Access
Biosimilars offer major cost savings over brand-name biologics, but insurance plans often block access through prior authorization and identical tier placement. Learn how formulary rules and PBM practices limit adoption-and what’s changing in 2025.
View More
